Switzerland and its long-standing sector cluster in life sciences provide fertile ground for biotech companies.
The financial industry has been involved in Life Sciences since the inception and therefore has a long tradition in the industry. . As a result of this conducive environment, the Swiss life sciences industry not only generates its own success stories in the field of biotech and drug development but is also attracting companies from abroad. This is also reflected on the SIX Swiss Exchange which represents the financial center function. In recent years two out of three biotech IPOs were cross-border listings. Read in this section what the finance place Switzerland can offer.
